←
OpenEvidence651 posts
OpenEvidence avatar✓

OpenEvidence ✓

@OpenEvidence

OpenEvidence is the most popular AI for doctors in the United States. Founded with the mission to organize and expand the world's collective medical knowledge.

◷ Joined November 2022▧ 120 Photos and videos
OpenEvidence avatar
OpenEvidence@OpenEvidence·Oct 22

Over 85% of oncologists at Memorial Sloan Kettering Cancer Center use OpenEvidence. Together, @MSKCancerCenter and OpenEvidence have built OncoKB, MSK’s expert interpretation of a tumor’s genetics, directly into OpenEvidence, putting it in the hands of oncologists across the United States. As Dr. Anaeze Offodile puts it: “Our mission is to end cancer for life.” As of today, we are widening OncoKB’s reach so that patients everywhere benefit from the same rigor as patients at MSK. Watch the story.

2:29
Travis Zack MD avatar
⟳ OpenEvidence retweeted
Travis Zack MD@TravisZack2·Nov 16

We know Patients are using AI tools to get information about their health. At OpenEvidence, we have long talked about building a tool for patients with the same evidence engine clinician is using. Excited to study such a tool with Apple during this collab

Berci Meskó, MD, PhD avatar
⟳ OpenEvidence retweeted
Berci Meskó, MD, PhD@Berci·Nov 16

BREAKING NEWS! What a Monday morning! Apple and OpenEvidence just launched an experimental health chat app The Apple Health AI Usage Study app was designed to answer health questions only using trusted medical research and based on your health metrics and records. "The study will also explore how health AI can potentially help participants better prepare for clinical visits with their own doctors and will ask the user for feedback along the way about how the experience is going.  For example, someone asking how to improve their resting heart rate could receive advice based on their own health measurements, rather than general recommendations." It's big news for both companies! Apple wants to use AI to help its users get the medical information and health insights they need, similarly to how ChatGPT launched ChatGPT Health and Anthropic launched Claude for healthcare. OpenEvidence so far has been focusing on building AI for medical professionals and now turns towards general consumers too. The question is whether this collaboration is going to mean enough trust for Apple users to share their health data and use the service. If you are an Apple user, please share your thoughts! Source: abcnews.com/US/apple-launche…

Post attachment
David Fajgenbaum, MD avatar
⟳ OpenEvidence retweeted
David Fajgenbaum, MD@DavidFajgenbaum·Nov 16

We are so thrilled about this partnership with @OpenEvidence, the physicians we'll be able to reach, and the impact we'll be able to make for patients! Excited to work with Daniel Nadler and his team on this important mission!

Post attachment
OpenEvidence avatar
OpenEvidence@OpenEvidence·Nov 16

The drug that saved @DavidFajgenbaum's life has been on pharmacy shelves for decades. It was approved for kidney transplants. He nearly died of Castleman disease and had been told there was nothing left to try. Thousands of diseases have no FDA-approved treatment. For some of them, the answer may already be sitting in a pharmacy. Nobody has run the trial. @EveryCure, the nonprofit he co-founded, exists to run these trial. Starting today, we’re working with them. OpenEvidence will help evaluate repurposing hypotheses, connect each program with the few physicians who actually treat the disease, and bring trial results back to the point of care when they land. Many of these are generic drugs. No one has a commercial reason to study them. That is exactly why a nonprofit has to.

Post attachment
OpenEvidence avatar
OpenEvidence@OpenEvidence·Nov 16

“OpenEvidence is the most trusted and loved brand product among doctors. Apple is the most trusted and loved brand and product among consumers, and especially health consumers. So you have to bring these two things together. It’s like peanut butter and jelly.” --OpenEvidence CEO Daniel Nadler

Katy Beckermann avatar
⟳ OpenEvidence retweeted
Katy Beckermann@katy_beckermann·Nov 13

Guidelines tell us what to do with new data. They're much less help with the patient in clinic who never would have made it into the trial. @OpenEvidence and the Uromigos are bringing expert opinion in to help with those gaps. It doesn't replace the guidelines 🤝. Look forward to see this roll out #urovoices #uromigos

Post attachment
Samyukta Mullangi avatar
⟳ OpenEvidence retweeted
Samyukta Mullangi@SamyuktaMD·Nov 12

Taking a theoretical treatment plan and effectuating into practice implies taking cost into account! So proud of the team for this

0:50
Sauren Khosla avatar
⟳ OpenEvidence retweeted
Sauren Khosla@Saurenk72·Nov 11

While the end user of OpenEvidence is a clinician, everything we do is in service of providing those providers and, subsequently, their patients, with the resources they need to make informed decisions. Today, we take a big step into incorporating more resources beyond clinical evidence to support those decisions with Access Intelligence.

0:50
OpenEvidence avatar
OpenEvidence@OpenEvidence·Nov 11

A prescription the patient can't afford, or the payer won't approve, doesn't treat anything. Today we launched Access Intelligence: copay savings, patient assistance, program enrollment, and prior authorization, inside OpenEvidence. Free for all clinicians. The help exists. There are thousands of support programs, and prior auths can be won. But the work is scattered across payers and programs, each with its own forms and criteria, and you have a few minutes per patient. What's live now: * Ask about availability and eligibility across 2,500+ patient support programs, updated daily. * Send copay savings and discount offers to the patient with Patient TakeHome. * Download pre-populated enrollment forms, or enroll on OpenEvidence. * Write prior auth requests, appeals, and letters of medical necessity grounded in clinical guidelines, with PA checklists and relevant ICD-10 codes. Choosing the right treatment should be the hardest part of getting a patient treated.

0:50